Perspectives by Leerink Partners
Melanie Whittington, PhD, Head of the Leerink Center for Pharmacoeconomics interviews Holly Krasa, CEO of Blue Persimmon Group. In this episode they discuss the recent CPE Exclusive: Cobenfy™ for Adults Living with Schizophrenia, the need for innovation in schizophrenia, and the importance of listening to the stories from people living with schizophrenia.
17 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Perspectives by Leerink Partners-fællesskabet!